| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.2 |